Drug Profile
JBM TC4
Alternative Names: JBM-TC-4Latest Information Update: 04 Apr 2017
Price :
$50
*
At a glance
- Originator Joben Bio-Medical
- Class Herbal medicines; Ketones; Lactams; Skin disorder therapies; Spiro compounds
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Radiodermatitis
Most Recent Events
- 04 Apr 2017 Phase-II development for Radiodermatitis (Treatment and Prevention in breast cancer patients) is ongoing in Taiwan (PO)
- 01 Nov 2014 Phase-II clinical trials in Radiodermatitis (Treatment and Prevention) in Taiwan (PO)